Publicacions
-
Amuge P, Lugemwa A, Wynne B, Mujuru HA, Violari A, Kityo CM, Archary M, Variava E, White E, Turner RM, Shakeshaft C, Ali S, Nathoo KJ, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa AR, Giaquinto C, Rojo P, Gibb DM, Turkova A and Ford D.
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
Lancet HIV . 9(9): 638-648. Nº de cites: 20
-
Turkova A, Waalewijn H, Chan MK, Bollen PDJ, Bwakura-Dangarembizi MF, Kekitiinwa AR, Cotton MF, Lugemwa A, Variava E, Ahimbisibwe GM, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo CM, Archary M, Ferrand RA, Violari A, Gibb DM, Burger DM, Ford D and Colbers A.
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Lancet HIV . 9(9): 627-637. Nº de cites: 17
-
Ortiz-Gracia A, Rios-Barnés M, Tobías E, Noguera-Julian A, García-García FJ, Cantó-Santos J, Valls-Roca L, Garrabou G, Grau JM, Cardellach F, Sánchez E, Morén C and Fortuny-Guasch C.
Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
ARCHIVES OF DISEASE IN CHILDHOOD . 107(7): 686-691.
-
Simó-Nebot S, López-Ramos MG, Velasco E, Jordán-García I, Fortuny-Guasch C and Noguera-Julian A.
Impact and quality of antimicrobial use in a referral pediatric intensive care unit.
enfermedades infecciosas y microbiologia clinica (english ed.) . 40(2): 78-81.
-
Simó-Nebot S, López-Ramos MG, Velasco E, Jordán-García I, Fortuny-Guasch C and Noguera-Julian A.
Impact and quality of antimicrobial use in a referral pediatric intensive care unit
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 40(2): 78-81. Nº de cites: 6
-
Chappell E, Kohns Vasconcelos M, Goodall RL, Galli L, Goetghebuer T, Noguera-Julian A, Rodrigues LC, Scherpbier H, Smit C, Bamford A, Crichton S, Navarro ML, Ramos JT, Warszawski J, Spolou V, Chiappini E, Venturini E, Prata F, Kahlert C, Marczynska M, Marques L, Naver L, Thorne C, Gibb DM, Giaquinto C, Judd A, Collins IJ and European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC).
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV MEDICINE . 23(2): 186-196. Nº de cites: 2
-
Dobaño C, Alonso S, Vidal M, Jiménez A, Rubio R, Santano R, Barrios D, Pons Tomas G, Melé Casas M, Hernández García M, Girona M, Puyol L, Baro B, Millat-Martínez P, Ajanovic S, Balanza N, Arias S, Rodrigo Melero N, Carolis C, García-Miquel A, Bonet-Carné E, Claverol J, Cubells M, Fortuny-Guasch C, Fumadó V, Codina-Bergadà A, Bassat Q, Munoz-Almagro C, Fernández de Sevilla-Estrach M, Gratacós E, Izquierdo L, García-García JJ, Aguilar R, Jordán-García I and Moncunill G.
Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts
FRONTIERS IN IMMUNOLOGY . 13: 751705-751705. Nº de cites: 18
-
Vieira VA, Millar J, Adland E, Muenchhoff M, Roider J, Fortuny-Guasch C, Peluso D, Thomé B, Garcia-Guerrero MC, Puertas MC, Bamford A, Brander C, Carrington M, Martinez-Picado J, Frater J, Tudor-Williams G and Goulder P.
Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
Aids . 36(1): 95-105. Nº de cites: 19
-
Jordán-García I, Fernández de Sevilla-Estrach M, Fumadó V, Bassat Q, Bonet E, Fortuny-Guasch C, Garcia-Miquel A, Jou-Munoz C, Adroher C, Casas MM, Girona M, Garcia MH, Tomas GP, Ajanovic S, Arias S, Balanza N, Baro B, Millat-Martinez P, Varo R, Alonso S, Álvarez-Lacalle E, López D, Claverol J, Cubells M, Brotons-de los Reyes P, Codina-Bergadà A, Cuadras-Palleja D, Bruijning-Verhagen P, Faust S, Munro A, Munoz-Almagro C, Català M, Prats C, García-García JJ and Gratacós E.
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children in Summer Schools Applying Stringent Control Measures in Barcelona, Spain
CLINICAL INFECTIOUS DISEASES . 74(1): 66-73. Nº de cites: 17
-
Dobaño C, Alonso S, Fernández de Sevilla-Estrach M, Vidal M, Jiménez A, Pons Tomas G, Jairoce C, Melé Casas M, Rubio R, Hernández García M, Ruiz-Olalla G, Girona M, Barrios D, Santano R, Mitchell RA, Puyol L, Mayer L, Chi J, Rodrigo Melero N, Carolis C, Garcia-Miquel A, Bonet-Carne E, Claverol J, Cubells M, Fortuny-Guasch C, Fumadó V, Jou-Munoz C, Munoz-Almagro C, Izquierdo L, Bassat Q, Gratacós E, Aguilar R, García-García JJ, Moncunill G and Jordán-García I.
Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain
BMC MEDICINE . 19(1): 309-309. Nº de cites: 11